Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | $56.15M | $38.41M | 31.82% | -$17.75M |
| Nuvation Bio Inc.CL A(NUVB) | 13,072,340 | 13,072,340 | 0 | $29.94M | $34.77M | 28.81% | +$4.84M |
| Replimune Group, Inc.(REPL) | 2,461,319 | 1,975,203 | -486,116 | $26.98M | $23.92M | 19.82% | -$3.06M |
| Lexeo Therapeutics, Inc.(LXEO) | 2,355,904 | 1,184,636 | -1,171,268 | $21.30M | $7.79M | 6.46% | -$13.50M |
| Alumis Inc | 653,223 | 653,223 | 0 | $6.98M | $5.13M | 4.25% | -$1.84M |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | $3.89M | $3.69M | 3.06% | -$202.4K |
| enGene Holdings Inc. COM | 1,076,357 | 526,357 | -550,000 | $7.10M | $3.50M | 2.90% | -$3.60M |
| Immunic, Inc.(IMUX) | 1,788,160 | 1,788,160 | 0 | $2.95M | $1.79M | 1.48% | -$1.16M |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $3.51M | $1.38M | 1.14% | -$2.13M |
| enGene Holdings Inc.WARRANT *W EXP 10/31/202 | 321,502 | 321,502 | 0 | $675.2K | $271.1K | 0.22% | -$404.0K |
| Syros Pharmaceuticals | 251,270 | 251,270 | 0 | $540.2K | $57.8K | 0.05% | -$482.4K |